With Immunotherapies, Patients May Live Though Tumors Grow
CHICAGO – At the American Society of Clinical Oncology (ASCO) annual meeting last week, there were plenty of individual trial results vying for attention. But there were also presentations that focused on the science of the trials: how one might make those trials better at observing the true effects of drugs on tumors and, ultimately, on patients.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST